tradingkey.logo

Halozyme Announces Global Collaboration And License Agreement With Takeda

ReutersJan 8, 2026 1:32 PM

- Halozyme Therapeutics Inc HALO.O:

  • HALOZYME ANNOUNCES GLOBAL COLLABORATION AND LICENSE AGREEMENT WITH TAKEDA TO DEVELOP AND COMMERCIALIZE VEDOLIZUMAB WITH ENHANZE®

  • HALOZYME THERAPEUTICS INC - TAKEDA GAINS EXCLUSIVE ACCESS TO ENHANZE TECHNOLOGY

  • HALOZYME THERAPEUTICS INC - TAKEDA TO MAKE UPFRONT AND MILESTONE PAYMENTS TO HALOZYME

  • HALOZYME THERAPEUTICS INC - TO RECEIVE ROYALTIES ON VEDOLIZUMAB SALES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI